Four Inc. Secures Spot on Washington Technology’s Top 100 Government Contractors List for 11th Consecutive Year 
Tat Hong Equipment Service Co., Ltd. Announces 2025/26 Annual Results Investor.com Welcomes StockTrader.com Into Its Domain
Trusted personal finance website investor.com is proud to announce it is the new home of…
Procore Revolutionizes Construction Workflows with Innovative AI-Powered Copilot
Procore Copilot will help customers make the next best decision by leveraging advanced artificial intelligence…
Tobacco Free Portfolios Celebrates 5-Year Anniversary of the Tobacco-Free Finance Pledge at United Nations Headquarters
‘There’s No Room for Tobacco in a Net Zero World’ NEW YORK–(BUSINESS WIRE)–Tobacco Free Portfolios…
University Students Set to Launch Most Powerful UK Reusable Rocket – Karman Space Programme
LONDON–(BUSINESS WIRE)–#Rocket–A team of university students in London is preparing to launch the most powerful…
Ultra Librarian to Dramatically Reduce CAD Model Build Times with New AI-Driven Part Creation Methodology
New Proprietary AI Enabled Process Helps Reduce CAD Model Creation Times from Hours to Seconds Rochester,…
Discern Security Lands Funding Round As It Launches World’s First AI Powered Security Policy Management Platform
Discern Security launches with a $3m funding round as it enhances the performance of cybersecurity…
Hepion Pharmaceuticals Discovers Novel Rencofilstat Action in Liver Cancer
– Research study demonstrates regulation of chromatin structure and cancer gene expression – – Findings…
Hepion Pharmaceuticals Discovers Novel Rencofilstat Action in Liver Cancer
– Research study demonstrates regulation of chromatin structure and cancer gene expression – – Findings…
Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials
Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only test…
Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials
Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only test…
Epic Bio to Present at Upcoming BMO Biopharma Spotlight Series Event
SOUTH SAN FRANCISCO, Calif., Sept. 19, 2023 (GLOBE NEWSWIRE) — Epic Bio, a biotechnology company…
Epic Bio to Present at Upcoming BMO Biopharma Spotlight Series Event
SOUTH SAN FRANCISCO, Calif., Sept. 19, 2023 (GLOBE NEWSWIRE) — Epic Bio, a biotechnology company…
T2 Biosystems Receives FDA 510(k) Clearance for the T2Biothreat Panel
The only FDA-cleared multi-target biothreat product developed and manufactured by a U.S. owned company LEXINGTON,…
T2 Biosystems Receives FDA 510(k) Clearance for the T2Biothreat Panel
The only FDA-cleared multi-target biothreat product developed and manufactured by a U.S. owned company LEXINGTON,…
Elevar Therapeutics Joins Benefactors Council of Blue Faery, Leading Hepatocellular Carcinoma Advocacy Group
FORT LEE, N.J., Sept. 19, 2023 (GLOBE NEWSWIRE) — Elevar Therapeutics, Inc., a majority-owned subsidiary…
Elevar Therapeutics Joins Benefactors Council of Blue Faery, Leading Hepatocellular Carcinoma Advocacy Group
FORT LEE, N.J., Sept. 19, 2023 (GLOBE NEWSWIRE) — Elevar Therapeutics, Inc., a majority-owned subsidiary…
Parexel Appoints Gwyn Bebb, BM, BCh., Ph.D., to Lead Oncology Clinical Development
Appointment further strengthens company’s expertise in fastest-growing therapeutic area to meet patient need Parexel Gwyn Bebb,…
Parexel Appoints Gwyn Bebb, BM, BCh., Ph.D., to Lead Oncology Clinical Development
Appointment further strengthens company’s expertise in fastest-growing therapeutic area to meet patient need Parexel Gwyn Bebb,…
ContraFect to Present at the ASM/ESCMID Joint Conference on Drug Development
YONKERS, New York, Sept. 19, 2023 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq: CFRX), a clinical-stage…
ContraFect to Present at the ASM/ESCMID Joint Conference on Drug Development
YONKERS, New York, Sept. 19, 2023 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq: CFRX), a clinical-stage…